Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 850

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Name:	us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Related Party Transactions (Details) - SmartPharma	3 Months Ended		9 Months Ended
Related Party Transactions (Details) - SmartPharma	Sep. 30, 2015 USD ($)	Sep. 30, 2014 USD ($)	Sep. 30, 2015 USD ($)	Sep. 30, 2014 USD ($)	Mar. 17, 2014 person
Related party transactions
Number of Managing Partners appointed to Chief Commercial Officer					1
Commercial and business development consulting services
Related party transactions
Fees invoiced by the related party \| $	$ 17,544	$ 26,100	$ 61,694	$ 100,400